Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies

American Journal of Epidemiology

Volumn 149, Issue 3, 1999, Pages 282-289

  Guevara, Ramon E ^a   Butler, Jay C ^a,e   Marston, Barbara J ^b   Plouffe, Joseph F ^c   File Jr , Thomas M ^d   Breiman, Robert F ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d SUMMA HEALTH SYSTEM   (United States)

^e NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

Bacteremia; Classification; ICD 9 CM; Pneumococcal infections; Predictive value of tests; Sensitivity and specificity; Streptococcus pneumoniae; Vaccines

Indexed keywords

PNEUMOCOCCUS VACCINE;

ACCURACY; ADULT; ARTICLE; CLASSIFICATION; CODING; DRUG EFFICACY; HUMAN; INCIDENCE; LOBAR PNEUMONIA; MAJOR CLINICAL STUDY; PREDICTION; RESPIRATORY FAILURE; SEPTICEMIA; STREPTOCOCCUS PNEUMONIA; VACCINATION;

EID: 0033080894     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009804     Document Type: Article

References (16)

1. Broome CV, Facklam RR, Fraser DW. Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med 1980;303:549-52.
2. Shapiro ED, Clemens JD. A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections. Ann Intern Med 1984;101:325-30.
3. Bolan G, Broome CV, Facklam RR, et al. Pneumococcal vaccine efficacy in selected populations in the United States. Ann Intern Med 1986;104:1-6.
4. Sims RV, Steinmann WC, McConville JH, et al. The clinical effectiveness of pneumococcal vaccine in the elderly. Ann Intern Med 1988;108:653-7.
5. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991;325:1453-60.
6. Butler JC, Breiman RF, Campbell JF, et al. Polysaccharide pneumococcal vaccine efficacy: an evaluation of current recommendations. JAMA 1993;270:1826-31.
7. Farr BM, Johnston BL, Cobb DK, et al. Preventing pneumococcal bacteremia in patients at risk: results of a matched case-control study. Arch Intern Med 1995;155:2336-40.
8. Simberkoff MS, Cross AP, Al-Ibrahim M, et al. Efficacy of pneumococcal vaccine in high-risk patients: results of a Veterans Administration cooperative study. N Engl J Med 1986;315:1318-27.
9. Marrie TJ, Haldane EV, Faulkner RS, et al. Community-acquired pneumonia requiring hospitalization. Is it different in the elderly? J Am Geriatr Soc 1985;33:671-80.
10. Gable CB, Holzer SS, Engelhart L, et al. Pneumococcal vaccine: efficacy and associated cost savings. JAMA 1990;264: 2910-15.
11. Marston BJ, Plouffe JF, File TM, et al. Incidence of community-acquired pneumonia requiring hospitalization: results of population-based active surveillance in Ohio. Arch Intern Med 1997;157:1709-18.
12. Dowell SF, Anderson LJ, Gary HE, et al. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Infect Dis 1996;174:456-62.
13. Gray GC, Mitchell BS, Tueller JE, et al. Pneumonia hospitalizations in the US Navy and Marine Corps: rates and risk factors for 6,522 admissions, 1981-1991. Am J Epidemiol 1994; 139:793-802.
14. Medicode, Inc. Med-index ICD-9-CM, 4th ed. 1994: international classification of diseases, 9th revision, clinical modification, vols 1 & 2. Salt Lake City, UT: Medicode, Inc, 1993.
15. Musher DM. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity and treatment. Clin Infect Dis 1992;14:801-7.
16. Marrie TJ, Durant H, Sealy E. Pneumonia - the quality of medical records data. Med Care 1987;25:20-4.